These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 307481)

  • 1. T- and B-lymphocytes in disease.
    Rabin BS; Whiteside TL; Kelly RH
    Compr Ther; 1978 Jul; 4(7):68-73. PubMed ID: 307481
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytochemical and immunologic characteristics of peripheral blood lymphocytes in myeloma].
    Abramenko IV; Nadgornaia VA; Skliarenko LM; Poludnenko LIu
    Vrach Delo; 1983 Sep; (9):79-82. PubMed ID: 6606267
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of thymus-dependent and bursa-dependent lymphocytes (T and B) in some lymphoproliferative diseases].
    Barabino A; Di Benedetto G; Franceschini R; Indiveri F; Puppo F; Soldà AM
    Boll Soc Ital Biol Sper; 1975 Nov; 51(22):1612-6. PubMed ID: 1084753
    [No Abstract]   [Full Text] [Related]  

  • 4. [T-and B-lymphocytes in lymphoproliferative syndromes].
    Girard JP; Fernandes B
    Schweiz Med Wochenschr; 1975 Sep; 105(37):1174-9. PubMed ID: 814616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunosuppressor activity of B-cells in patients with chronic lymphocytic leukemia. Their possible role in the pathogenesis of the disease].
    Chernykh ER; Tikhonova MA; Ostanin AA; Shevela EIa; Blazhievich IA; Shubinskiĭ GZ
    Vestn Akad Med Nauk SSSR; 1991; (12):39-43. PubMed ID: 1801472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible lymphokines of T cell tumors.
    Corley RB; Dexter CM; Ovnic M
    Crit Rev Immunol; 1986; 6(1):71-103. PubMed ID: 3522104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [T and B lymphocytes in humans. Lymphocytes with membrane immunoglobulins in normal and pathological conditions].
    Aiuti F; Lacava V; D'Asero C; Ciarla MV; D'Amelio R; Fiorilli M
    Recenti Prog Med; 1973 Feb; 54(2):124-51. PubMed ID: 4541383
    [No Abstract]   [Full Text] [Related]  

  • 8. [Suppressor T- and B-lymphocytes].
    Khaitov RM
    Probl Gematol Pereliv Krovi; 1981 Oct; 26(10):48-54. PubMed ID: 6459576
    [No Abstract]   [Full Text] [Related]  

  • 9. Circulating B and T lymphocytes in myeloma and benign monoclonal gammopathies.
    Büchi G; Termine G; Girotto M; Gario S; Autino R
    Haematologica; 1983; 68(2):179-89. PubMed ID: 6407913
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recent acquisitions regarding the functions and relationships between T- and B-lymphocytes].
    Sacerdoti G; Alviggi L; Altucci P
    Recenti Prog Med; 1976 Nov; 61(5):630-61. PubMed ID: 799327
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the cell surface markers of lymphocytes in lymphoproliferative disorders (author's transl)].
    Tanaka E
    Rinsho Ketsueki; 1976 Jun; 17(6):600-17. PubMed ID: 823349
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of a factor from multiple sclerosis serum on isolated T and B lymphocytes.
    Armentrout SA; Sweet PM; Galant SP
    J Clin Lab Immunol; 1981 May; 5(3):133-6. PubMed ID: 6972451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monoclonal antibodies IPO-4 recognizing antigen-activated human T and B lymphocytes].
    Sidorenko SP; Berdova AG; Vetrova EP; Shlapatskaia LN; Iurchenko OV; Evsev'eva AI; Gluzman DF
    Eksp Onkol; 1990; 12(3):21-4. PubMed ID: 2344819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease.
    Pilarski LM; Giannakopoulos NV; Szczepek AJ; Masellis AM; Mant MJ; Belch AR
    Clin Cancer Res; 2000 Feb; 6(2):585-96. PubMed ID: 10690543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of immunoregulatory cells in immunodeficiency disease and cancer.
    Broder S; Muul L; Megson M; Waldmann TA
    Prog Clin Biol Res; 1981; 58():93-120. PubMed ID: 6455670
    [No Abstract]   [Full Text] [Related]  

  • 16. T-lymphocytes in B-cell chronic lymphocytic leukaemia.
    Lauria F; Foà R
    Haematologica; 1985; 70(5):445-50. PubMed ID: 2419209
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhanced T cell suppression is directed toward sensitive circulating B cells in multiple myeloma.
    Perri RT; Oken MM; Kay NE
    J Lab Clin Med; 1982 Apr; 99(4):512-9. PubMed ID: 6460827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extremely high serum transcortin levels in patients with acute B and T-cell-type lymphatic leukemia and extremely low transcortin levels in patients with multiple myeloma and an excess of light lambda chains].
    De Moor P; Boogaerts M; Faict D; Louwagie A
    Verh K Acad Geneeskd Belg; 1987; 49(5):371-91. PubMed ID: 3122431
    [No Abstract]   [Full Text] [Related]  

  • 19. Soluble factor mediated T cell, B cell, and macrophage interactions in the regulation of the immune response in man.
    Warrington RJ; Wilkins JA
    Lymphokine Res; 1984; 3(3):137-44. PubMed ID: 6611468
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphokine regulation of polyclonal and antigen-specific B cell responses.
    Howard M; Stein P; Dubois P
    Symp Fundam Cancer Res; 1986; 38():35-42. PubMed ID: 3489262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.